132.02
price down icon1.18%   -1.58
pre-market  プレマーケット:  132.30   0.28   +0.21%
loading
前日終値:
$133.60
開ける:
$133.27
24時間の取引高:
4.66M
Relative Volume:
0.71
時価総額:
$233.36B
収益:
$42.34B
当期純損益:
$13.50B
株価収益率:
17.12
EPS:
7.71
ネットキャッシュフロー:
$6.66B
1週間 パフォーマンス:
-1.80%
1か月 パフォーマンス:
-2.41%
6か月 パフォーマンス:
+17.55%
1年 パフォーマンス:
+26.72%
1日の値動き範囲:
Value
$131.26
$133.58
1週間の範囲:
Value
$131.26
$135.05
52週間の値動き範囲:
Value
$99.71
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1164)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2025-04-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
132.02 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
103.20 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
389.46 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
89.92 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.05 44.46B 5.54B 4.18B 623.10M 7.00

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
04:17 AM

Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships - Yahoo Finance

04:17 AM
pulisher
12:42 PM

3 Profitable Stocks to Research Further - FinancialContent

12:42 PM
pulisher
Jul 12, 2025

Dividend Information and Latest News on Abbott Laboratories Ahead of Its Ex-Dividend Date on Jul 15, 2025 - AInvest

Jul 12, 2025
pulisher
Jul 11, 2025

Abbott Labs stock price target reiterated at $145 by TD Cowen on strong outlook - Investing.com UK

Jul 11, 2025
pulisher
Jul 10, 2025

Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Jul 10, 2025
pulisher
Jul 10, 2025

Abbott Laboratories Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily

Jul 10, 2025
pulisher
Jul 09, 2025

Abbott Laboratories Positioned for Growth: Buy Rating Supported by Strong Operational Momentum and Favorable Market Conditions - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Is It Time To Buy Abbott Stock Now? - Nasdaq

Jul 09, 2025
pulisher
Jul 09, 2025

Abbott Laboratories (NYSE:ABT) Expands Diabetes Care with FreeStyle Libre 3 Plus Launch in Canada - simplywall.st

Jul 09, 2025
pulisher
Jul 09, 2025

Oppenheimer Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT) - Insider Monkey

Jul 09, 2025
pulisher
Jul 09, 2025

Should You Buy Abbott Stock At $135? - Forbes

Jul 09, 2025
pulisher
Jul 08, 2025

Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Jul 08, 2025
pulisher
Jul 08, 2025

Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga

Jul 08, 2025
pulisher
Jul 06, 2025

2 Dividend Stocks to Buy for Decades of Passive Income - The Motley Fool

Jul 06, 2025
pulisher
Jul 02, 2025

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance

Jul 02, 2025
pulisher
Jul 01, 2025

Abu Dhabi Pharmaceutical Partnership Could Be A Game Changer For Abbott Laboratories (ABT) - simplywall.st

Jul 01, 2025
pulisher
Jun 30, 2025

What to Expect From Abbott Laboratories' Q2 2025 Earnings Report - MSN

Jun 30, 2025
pulisher
Jun 30, 2025

What To Expect From Abbott Laboratories' Q2 2025 Earnings Report - Barchart.com

Jun 30, 2025
pulisher
Jun 28, 2025

Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance

Jun 28, 2025
pulisher
Jun 25, 2025

State awards $500,000 for realignment of Bishop Road and Nims Road for Abbott Labs site in BG - BG Independent News

Jun 25, 2025
pulisher
Jun 24, 2025

OUR PEOPLE AND CULTURE - Abbott

Jun 24, 2025
pulisher
Jun 24, 2025

Abbott Defeats Whistleblower Suit Over Diabetic Supplies Bills - Bloomberg Law News

Jun 24, 2025
pulisher
Jun 23, 2025

The Zacks Analyst Blog Highlights Meta, Palantir, Abbott Laboratories, SandRidge and CompX - Nasdaq

Jun 23, 2025
pulisher
Jun 20, 2025

Life Experiences Shape Our Work - Abbott

Jun 20, 2025
pulisher
Jun 19, 2025

Is Trending Stock Abbott Laboratories (ABT) a Buy Now? - Yahoo Finance

Jun 19, 2025
pulisher
Jun 18, 2025

India Medical Nutrition Market Future Trends and Scope Analysis - openPR.com

Jun 18, 2025
pulisher
Jun 18, 2025

Abbott, MSD Forge Diabetes‑Drug Pact For Wider Indian Reach - BW Healthcare World

Jun 18, 2025
pulisher
Jun 18, 2025

Abbott Labs stock price target maintained at $140 by Oppenheimer - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Leerink Partners Begins Coverage on ABT - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

10 Best Dividend Stocks to Buy for Dependable Dividend Growth - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Who Rules Homecare Clinical Nutrition Market? Abbott, Danone, - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

Health Canada approves Abbott’s i-STAT TBI test for suspected concussions - Medical Device Network

Jun 17, 2025
pulisher
Jun 17, 2025

Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent

Jun 17, 2025
pulisher
Jun 16, 2025

Abbott (ABT) Stock Dips While Market Gains: Key Facts - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

Eaton makes a move outside of the data center — plus, what's new with Abbott Labs - CNBC

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Wins Dismissal of Whistleblower’s Medicare Fraud Suit - Bloomberg Law News

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Declares 406th Consecutive Quarterly Dividend - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Laboratories' Whole Blood Concussion Test Approved by Health Canada - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions - Barchart.com

Jun 16, 2025
pulisher
Jun 16, 2025

Blood Screening Market Outlook | Key Players: Abbott Laboratories, Roche, Grifols, BioMérieux - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Deep Venous Disease Treatment Market Key Players Analysis - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

1 Unpopular Stock that Should Get More Attention and 2 to Avoid - FinancialContent

Jun 16, 2025
pulisher
Jun 15, 2025

Jim Cramer Calls Abbott “Really Excellent” - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

Electrophysiology Devices Market Share Leaders: Abbott, Acutus Medical, and Biosense Webster - openPR.com

Jun 14, 2025
pulisher
Jun 13, 2025

Abbott Laboratories (ABT) Maintains Quarterly Dividend of $0.59 - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Declares 406Th Consecutive Quarterly Dividend, Payable on August 15, 2025 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Laboratories Keeps Quarterly Dividend at $0.59 per Share, Payable August 15 to Shareholders as of July 15 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Clinical Immunochemistry Analyzers Market projected reach USD 6.9 billion by 2034, growing at a CAGR of 4.4% | Exactitude Consultancy - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 12, 2025

Abbott Laboratories Stock Sees RS Rating Rise To 82 - Investor's Business Daily

Jun 12, 2025

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices BSX
$103.20
price down icon 0.64%
medical_devices SYK
$389.46
price down icon 1.35%
medical_devices MDT
$89.92
price up icon 0.58%
medical_devices EW
$78.05
price down icon 0.95%
$75.13
price down icon 1.79%
大文字化:     |  ボリューム (24 時間):